LANXESS: Update on ENVALIOR Stake

  • Advent HoldCo will in 2026 not take over LANXESS’ shares in the ENVALIOR joint venture
  • LANXESS remains solidly financed; repayment of the bond due in October already secured 

Cologne, March 5, 2026 – Advent HoldCo will in 2026 not acquire the LANXESS stake in the ENVALIOR joint venture that LANXESS had tendered in September 2025. Advent HoldCo has now informed the specialty chemicals company accordingly, referring to its contractually agreed financing condition. As a result, the additional tender and purchase periods for LANXESS’ shares in ENVALIOR in the years 2027 and 2028 now apply, as described in the ad hoc announcement of September 23, 2025.

LANXESS will continue to play an active role as a committed joint venture partner in shaping the expected positive development of ENVALIOR. According to LANXESS, key drivers of this development include the recovery of the market, synergy effects between the two companies brought into the joint venture as well as consolidation among direct competitors.

Even without proceeds from a sale of its ENVALIOR stake in 2026, LANXESS is solidly financed. The company holds a strong cash position as well as undrawn, firmly committed credit lines totaling more than EUR 1.35 billion. Therefore, repayment of the bond maturing in October 2026 is already ensured. The financing instruments are not subject to any financial covenants.

In addition, LANXESS continues to have unrestricted and broad access to the debt capital markets.

Reducing financial debt remains a high priority for LANXESS.

LANXESS will publish its financial results for the year 2025 on March 19, 2026.


Information for editors:
All global LANXESS news releases and their accompanying photos can be found at http://press.lanxess.com.
Recent photos of the Board of Management and other LANXESS image material are available at http://photos.lanxess.com.

 

MORE ABOUT THIS TOPIC

INVESTOR NEWS

Challenging market environment shapes third quarter of 2025

November 06, 2025
INVESTOR NEWS

LANXESS exercises right to offer for the sale of its shares in Envalior in 2026

September 23, 2025
AD HOC

LANXESS exercises right to offer for the sale of its shares in Envalior in 2026

September 23, 2025
INVESTOR NEWS

LANXESS takes action to counter weak market environment

August 14, 2025
INVESTOR NEWS

LANXESS starts fiscal year 2025 with significant earnings increase

May 08, 2025